Resultats de la cerca - Quentin M. Anstee

Refinar resultats
  1. 1
    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research per Quentin M. Anstee, Robert Goldin

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 per Christopher P. Day, Quentin M. Anstee

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility

    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility per Quentin M. Anstee, Christopher P. Day

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment per Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis per Mazen Noureddin, Quentin M. Anstee, Rohit Loomba

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease per Marie Boyle, Steven Masson, Quentin M. Anstee

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Impact of non-invasive biomarkers on hepatology practice: Past, present and future

    Impact of non-invasive biomarkers on hepatology practice: Past, present and future per Quentin M. Anstee, Laurent Castéra, Rohit Loomba

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease per Timothy Hardy, Quentin M. Anstee, Christopher P. Day

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Non-alcoholic fatty liver disease: a practical approach to treatment

    Non-alcoholic fatty liver disease: a practical approach to treatment per Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging per Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    NAFLD-Associated HCC: Progress and Opportunities

    NAFLD-Associated HCC: Progress and Opportunities per Daniel Geh, Quentin M. Anstee, Helen L. Reeves

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Genetic modifiers of non-alcoholic fatty liver disease progression

    Genetic modifiers of non-alcoholic fatty liver disease progression per Quentin M. Anstee, Ann K. Daly, Christopher P. Day

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    How big a problem is non-alcoholic fatty liver disease?

    How big a problem is non-alcoholic fatty liver disease? per Quentin M. Anstee, Stuart McPherson, C.P. Day

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases per Leon A. Adams, Quentin M. Anstee, Herbert Tilg, Giovanni Targher

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    The Global Burden of Liver Disease

    The Global Burden of Liver Disease per Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin M. Anstee, Linda Henry

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Thrombin and factor Xa link the coagulation system with liver fibrosis

    Thrombin and factor Xa link the coagulation system with liver fibrosis per Ameet Dhar, Fouzia Sadiq, Quentin M. Anstee, Adam Levene, Robert Goldin, Mark Thursz

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study

    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease... per Kate Hallsworth, Stephan U Dombrowski, Stuart McPherson, Quentin M. Anstee, Leah Avery

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease per Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis

    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis per Helen Jarvis, Hannah O’Keefe, Dawn Craig, Daniel Stow, Barbara Hanratty, Quentin M. Anstee

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice

    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice per Leah Avery, Catherine Exley, Stuart McPherson, Michael I. Trenell, Quentin M. Anstee, Kate Hallsworth

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: